Results 151 to 160 of about 3,196,403 (286)
Induction of specific Escherichia coli genes by sublethal treatments with alkylating agents. [PDF]
Michael R. Volkert, Dinh C. Nguyen
openalex +1 more source
Clickable Pyclen‐Based Luminescent Lanthanide Complexes: Application to Two‐Photon Microscopy
This work presents two pyclen‐based lanthanide complexes (Eu3+ and Sm3+) bearing an alkynyl‐linker dedicated to bioconjugation. Featuring strong luminescence and two‐photon (2P) absorption, they were conjugated to a cell‐penetrating peptide thanks to copper‐catalyzed azide‐alkyne cycloaddition. The resulting luminescent conjugates reach efficiently the
Baptiste Chartier+13 more
wiley +1 more source
BP(1‐6) compounds designed from Benzoxazole and Thiazolyl‐Pyrazole scaffolds exhibited potent antitubulin and caspase‐3 activity in MDA‐MB‐231 cells. BP‐6 notably triggered apoptosis and disrupted cell proliferation. Docking studies validated strong binding affinities of BP‐2 and BP‐6 toward β‐tubulin and caspase‐3, suggesting promising therapeutic ...
Burak Kuzu+3 more
wiley +1 more source
Heterohelicenes with multiple chiral axes have the potential to drive next‐generation technologies due to their unique structural and optoelectronic features. This review highlights innovative short‐step synthetic strategies for double and triple heterohelicenes, emphasizing their ease of preparation and valuable (chir)optical features, along with high
Mohamed S. H. Salem, Shinobu Takizawa
wiley +1 more source
Etched silicon powder‐supported Pd is developed as a durable and efficient catalyst for continuous flow hydrogenation and reductive alkylation. This study develops a novel heterogeneous palladium catalyst immobilized on etched silicon powder, demonstrating high efficiency and long‐term stability under continuous flow conditions.
Zhenzhong Zhang+4 more
wiley +1 more source
The Alkylating Agent, Dimethyl Sulphate, Stimulates ADP‐Ribosylation of Histone H1 and Other Proteins in Permeabilised Mouse Lymphoma (L1210) Cells [PDF]
Nguyen thi Mân, Sydney Shall
openalex +1 more source
Busulfan is administered intravenously in conditioning regimens prior to allogeneic hematopoietic stem cell transplantation (HSCT), with model‐informed precision dosing (MIPD) targeting a 4‐day cumulative AUC of 80–100 mg*hour/L. Three pharmacokinetic (PK) models—Bognar, Langenhorst, and McCune—were evaluated using data with a minimum of 1 and a median
Rashudy F. Mahomedradja+13 more
wiley +1 more source